美股异动丨杜邦盘前涨超2%，去年Q4调整后EPS超预期+今年业绩指引乐观

Core Viewpoint - DuPont's stock rose over 2% pre-market, reaching $48, following the announcement of its Q4 2025 earnings, which met expectations and showed positive growth in the healthcare sector [1] Financial Performance - DuPont reported net sales of $1.69 billion for Q4 2025, aligning with market expectations [1] - Adjusted earnings per share (EPS) were $0.46, surpassing analyst expectations of $0.43, driven by growth in the healthcare segment and business restructuring [1] Future Outlook - For 2026, DuPont projects adjusted EPS to be between $2.25 and $2.30, with net sales expected to range from $7.08 billion to $7.14 billion [1] - Analyst expectations for 2026 are slightly lower, with projected EPS at $2.14 and net sales at $7.06 billion [1]